Progress, Potential, and Possibilities Podcast / Show · 2026-06-29 · 36 min
Send us Fan Mail For decades, scientists have searched for better cancer drugs. But what if the biggest challenge isn't discovering the drug - it's getting it to the tumor? My guest today is developing programmable viruses designed to travel throughout the body, selectively amplify inside metastatic lesions, and transform tumors into factories for their own destruction. Dr. Eric Poma, Ph.D. is Chief Executive Officer of Calidi Biotherapeutics ( ), a biotechnology company developing targeted genetic medicines designed to deliver therapeutic payloads directly to tumors throughout the body. Dr. Poma brings more than three decades of experience across biotechnology, oncology drug development, business development, and capital markets. Prior to joining Calidi in 2025, he served as CEO of Molecular Templates, where he helped raise more than $250 million in equity financing and secured strategic partnerships with companies including Takeda, Vertex, and Bristol Myers Squibb. Earlier in his career, Dr.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio TherapeuticsCareTalk: Healthcare. Unfiltered. · on Oncology94 / 100
Navigating High-Cost Claims: Employer Strategies for Managing Complex Healthcare Cases with Dr. Christine Hale, Chief Medical Officer, US Benefits at GallagherThe Benefits Playbook · on Gene Therapy85 / 100
Ali Perez on Lockheed Martin Ventures, innovation, and startup collaboration in emerging tech | E29ImpacTV · on Biotechnology80 / 100
AstraZeneca's CFO on GLP-1 Drugs, AI, and MoreAt Barron's · on Oncology78 / 100
US Pharma Deals Midyear Outlook 2026: Why Dealmakers Are Leaning Into GrowthPwC's Next in Health · on Oncology76 / 100
Putting the “Tech” in Biotech: An Unconventional Path to Building a Therapeutics Company, with Federico Paoletti, PhDBuilding Biotechs · on Immunotherapy72 / 100Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-ColtonReversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart InstituteThe Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen